NCT07877415: A Multicenter Safety and Immunogenicity Window-of-opportunity Phase 1 Interventional Trial Assessing the Combination of IDH1 Vaccine (IDH1-vac) and Vorasidenib in Adult Patients With Recurrent IDH1R132H-mutant Astrocytoma, Grade 2 - 4 (iVOCAL)
- State
- Not started
- Phase
- Phase 1
- People
- 45 planned
- Started
- 1 Jan 2027
- Primary completion
- 31 Dec 2032
- Arms
- Main Therapy, Primary Treatment - Arm 1
- Results
- None posted
- 16 Oct 2026: Trial registered